Does ALEMTUZUMAB Cause Activated partial thromboplastin time prolonged? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Activated partial thromboplastin time prolonged have been filed in association with ALEMTUZUMAB (Campath). This represents 0.2% of all adverse event reports for ALEMTUZUMAB.
24
Reports of Activated partial thromboplastin time prolonged with ALEMTUZUMAB
0.2%
of all ALEMTUZUMAB reports
1
Deaths
20
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From ALEMTUZUMAB?
Of the 24 reports, 1 (4.2%) resulted in death, 20 (83.3%) required hospitalization, and 3 (12.5%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which ALEMTUZUMAB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET